DJ Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 1.77% to $188.83 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.13% to 7,609.78 and the Dow Jones Industrial Average rising 0.45% to 51,307.79.
This was the stock's fourth consecutive day of losses.
Biogen Inc. closed 8.32% short of its 52-week high of $205.97, which the company reached on May 13th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.28% to $222.89, Pfizer Inc. $(PFE)$ fell 0.31% to $25.55, and AbbVie Inc. $(ABBV)$ rose 1.16% to $215.40.
Trading volume (964,379) remained 267,831 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 02, 2026 16:59 ET (20:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments